Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 4, 2009, Pages 216-220

  Marin, Benoit ^a,b,c   Gil, Juan ^a,d,e   Preux, Pierre Marie ^a,b,c   Funalot, Benoit ^b,c   Couratier, Philippe ^a,b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF LIMOGES   (France)

^d DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^e Military University Hospital of Montevideo   (Uruguay)

Author keywords

Amyotrophic lateral sclerosis; Epidemiology; Incidence

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DEMOGRAPHY; DISEASE REGISTRY; FEMALE; FRANCE; HOSPITAL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; REGISTRIES;

EID: 70249095561     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960902721626     Document Type: Article

References (34)

1. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: A population-based study. Neurology. 1999;52:504-9.
2. The Scottish Motor Neuron Disease Register: A prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry. 1992;55: 536-41.
3. Yoshida S, Mulder DW, Kurland LT, Chu CP, Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology. 1986;5:61-70.
4. Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: Evidence for a uniform frequency in Western countries. Neurology. 2001;56:239-44.
5. Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: A population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094-8.
6. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141-5.
7. Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, et al. Incidence of amyotrophic lateral sclerosis and of the Parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology. 2004;23:192-200.
8. Yoshida S, Uebayashi Y, Kihira T, Kohmoto J, Wakayama I, Taguchi S, et al. Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989-1993: Active or disappearing focus? J Neurol Sci. 1998;155:146-55.
9. Vazquez MC, Ketzoian C, Legnani C, Rega I, Sanchez N, Perna A, et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: A population-based study. Neuroepidemiology. 2008;30:105-11.
10. Lai CH, Tseng HF. Epidemiology and medical expenses of motor neuron diseases in Taiwan. Neuroepidemiology. 2008;31:159-66.
11. Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor neuron disease in Hong Kong Chinese: Epidemiology and clinical picture. Neuroepidemiology. 1996;15:239-45.
12. Preux PM, Druet-Cabanac M, Couratier P, Debrock C, Truong T, Marcharia W, et al. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol. 2000;53: 1025-9.
13. Insee. Recensement de la population, mars 1999. 1999 [cited 2008 Sept 30]; Available from: http://www.recensement.in see.fr/RP99/rp99/ page_accueil.paccueil.
14. ORS du Limousin. Le contexte géographique et économique. 2003 [cited 2008 Sept 30]; Available from: http://www.ors-limousin.org/dmdocuments/contex_geo_eco.pdf.
15. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
16. Couratier P, Druet-Cabanac M, Truong CT, Bernet-Bernady P, Dumas M, Vallat JM, et al. Interest of a computerized ALS database in the diagnosis and follow-up of patients with ALS. Rev Neurol (Paris). 2000;156:357-63.
17. Desport JC, Marin B, Funalot B, Preux PM, Couratier P. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:273-8.
18. Preux PM, Couratier P, Boutros-Toni F, Salle JY, Tabaraud F, Bernet-Bernady P, et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology. 1996;15: 153-60.
19. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53:1059-63.
20. Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:91-6.
21. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328-34.
22. Couratier P, Vincent F, Torny F, Lacoste M, Melloni B, Lemaire F, et al. Spirometer-dependence of vital capacity in ALS: Validation of a portable device in 52 patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6:239-45.
23. Gil J, Preux PM, Alioum A, Ketzoian C, Desport JC, Druet-Cabanac M, et al. Disease progression and survival in ALS: First multi-state model approach. Amyotroph Lateral Scler. 2007;8:224-9.
24. Insee. Estimation annuelle de population au 1er janvier par région, département, sexe et âge, 1990-2006. 2006 [cited 2008 Sept 30]. Available from: http://www.insee.fr/fr/themes/ detail.asp?ref_id-estim-pop®_id-99.
25. US Census Bureau. United States 2000 Census. 2000 [cited 2008 Sept 30]; Available from: http://www.census.gov/main/www/cen2000.html.
26. Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta. 2006;1762:1150-7.
27. Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor neuron disease in Scotland. J Neurol. 2007;254: 866-9.
28. Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in south-east England: A population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology. 2007;29:44-8.
29. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: New evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6-11.
30. Alcaz S, Jarebinski M, Pekmezovic T, Stevic-Marinkovic Z, Pavlovic S, Apostolski S. Epidemiological and clinical characteristics of ALS in Belgrade, Yugoslavia. Acta Neurol Scand. 1996;94:264-8.
31. Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003;60:683-9.
32. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925-1998. Neurology. 2002;59:280-2.
33. O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30-2.
34. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: A systematic review. Neurology. 2007;68: 1002-7.